FDA clarifies policies for compounders as national GLP-1 supply …
Oct 3, 2024 · The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
Compounding pharmacies can resume making tirzepatide as FDA ... - NBC News
4 days ago · The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.
Lilly launches lower-price weight loss drug without injector pen - CNN
Aug 27, 2024 · The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both ...
Tirzepatide cuts risk of diabetes by 94% in adults with ... - CNN
Aug 20, 2024 · A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight...
FDA Approves New Medication for Chronic Weight Management
The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a...
News Release - Eli Lilly and Company
Aug 20, 2024 · In an additional key secondary endpoint, tirzepatide (10 mg and 15 mg) led to statistically significant weight reduction compared to placebo in adults with pre-diabetes and obesity or overweight from baseline to week 176 (p<0.001, controlled for type 1 error). For the efficacy estimand ii, adults taking tirzepatide achieved average weight ...
Lilly's tirzepatide successful in phase 3 study showing benefit in ...
Aug 1, 2024 · Eli Lilly and Company (NYSE: LLY) announced today positive topline results from the SUMMIT phase 3 clinical trial evaluating the safety and efficacy of tirzepatide injection (5 mg, 10 mg or 15 mg...
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete …
Nov 8, 2023 · Tirzepatide, which patients take by a self-administered injection once a week, as they do with Wegovy, could ease those shortages. Competition could also result in lower net prices for both...
FDA approves Eli Lilly drug tirzepatide for weight loss
Nov 8, 2023 · The Food and Drug Administration approved Eli Lilly’s tirzepatide drug for weight loss, paving the way for even wider use of the blockbuster medication. The active ingredient in the drug ...
Eli Lilly's tirzepatide cuts heart failure risks, company says - NBC News
Aug 1, 2024 · Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday.